Related references
Note: Only part of the references are listed.Preoperative Folate Receptor-Positive Circulating Tumor Cell Level Is a Prognostic Factor of Long Term Outcome in Non-Small Cell Lung Cancer Patients
Hang Li et al.
FRONTIERS IN ONCOLOGY (2021)
Exploiting the folate receptor α in oncology
Mariana Scaranti et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2020)
Folate receptor-positive circulating tumor cells as a predictive biomarker for the efficacy of first-line pemetrexed-based chemotherapy in patients with non-squamous non-small cell lung cancer
Xiaoxia Chen et al.
ANNALS OF TRANSLATIONAL MEDICINE (2020)
Ligand-targeted polymerase chain reaction for the detection of folate receptor-positive circulating tumour cells as a potential diagnostic biomarker for pancreatic cancer
Hao Cheng et al.
CELL PROLIFERATION (2020)
Beyond transrectal ultrasound-guided prostate biopsies: available techniques and approaches
Christopher Warlick et al.
WORLD JOURNAL OF UROLOGY (2019)
Value of folate receptor-positive circulating tumour cells in the clinical management of indeterminate lung nodules: A non-invasive biomarker for predicting malignancy and tumour invasiveness
Qianjun Zhou et al.
EBIOMEDICINE (2019)
Trends and age-period-cohort effect on incidence and mortality of prostate cancer from 1990 to 2017 in China
X. Liu et al.
PUBLIC HEALTH (2019)
Circulating Tumor Cells in Prostate Cancer: From Discovery to Clinical Utility
Klaus Pantel et al.
CLINICAL CHEMISTRY (2019)
Dynamic Monitoring and Predictive Value of Circulating Tumor Cells in EGFR-Mutated Advanced Non-Small-Cell Lung Cancer Patients Treated With First-Line EGFR Tyrosine Kinase Inhibitors
Tao Jiang et al.
CLINICAL LUNG CANCER (2019)
Toward a real liquid biopsy in metastatic breast and prostate cancer: Diagnostic LeukApheresis increases CTC yields in a European prospective multicenter study (CTCTrap)
Kiki C. Andree et al.
INTERNATIONAL JOURNAL OF CANCER (2018)
Predictive and prognostic value of folate receptor-positive circulating tumor cells in small cell lung cancer patients treated with first-line chemotherapy
Jiqiao Shen et al.
ONCOTARGET (2017)
Clinical Significance of Folate Receptor-positive Circulating Tumor Cells Detected by Ligand-targeted Polymerase Chain Reaction in Lung Cancer
Lin Wang et al.
JOURNAL OF CANCER (2017)
Challenges in circulating tumor cell detection by the CellSearch system
Kiki C. Andree et al.
MOLECULAR ONCOLOGY (2016)
Urologic cancer in China
Cheng Pang et al.
JAPANESE JOURNAL OF CLINICAL ONCOLOGY (2016)
Limited prognostic value of preoperative circulating tumor cells for early biochemical recurrence in patients with localized prostate cancer
Christian P. Meyer et al.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2016)
Detection and Phenotyping of Circulating Tumor Cells in High-Risk Localized Prostate Cancer
Sumanta K. Pal et al.
CLINICAL GENITOURINARY CANCER (2015)
Magnetic Resonance Imaging-targeted Biopsy May Enhance the Diagnostic Accuracy of Significant Prostate Cancer Detection Compared to Standard Transrectal Ultrasound-guided Biopsy: A Systematic Review and Meta-analysis
Ivo G. Schoots et al.
EUROPEAN UROLOGY (2015)
The folate receptor as a rational therapeutic target for personalized cancer treatment
Yehuda G. Assaraf et al.
DRUG RESISTANCE UPDATES (2014)
Quantitation of circulating tumor cells in blood samples from ovarian and prostate cancer patients using tumor-specific fluorescent ligands
Wei He et al.
INTERNATIONAL JOURNAL OF CANCER (2008)
Performance of tPSA and f/tPSA for prostate cancer in Chinese. A systematic review and meta-analysis
Y. Wang et al.
PROSTATE CANCER AND PROSTATIC DISEASES (2006)
Share Paper
